Quantifying Uric Acid Excretion With RDEA3170, Febuxostat and Dapagliflozin
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Dapagliflozin (Primary) ; Febuxostat (Primary) ; Verinurad (Primary)
- Indications Hyperuricaemia
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 30 Jul 2018 Status changed from active, no longer recruiting to completed.
- 11 Jun 2018 Status changed from recruiting to active, no longer recruiting.